Drug Approval Package

Megace ES (Megestrol Acetate) Oral Suspension
Company: Par Pharmaceutical Inc.
Application No.:  021778
Approval Date: 07/05/2005

• Approval Letter(s) (PDF)  

• Printed Labeling (PDF)  

• Medical Review(s) (PDF)

• Chemistry Review(s) (PDF)  

• Pharmacology Review(s) (PDF)  

• Clinical Pharmacology Biopharmaceutics Review(s) (PDF)  

• Administrative Document(s) & Correspondence (PDF)  

Date created:  July 02, 2007

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.